A photo of William Balisteri.

Dorothy M. M. Kersten Professor of Pediatrics

Director Emeritus, Pediatric Liver Care Center

Medical Director Emeritus, Liver Transplantation

Program Director Emeritus, Fellowship in Transplant Hepatology

Professor, UC Department of Pediatrics



Board Certified

Best Doctors logo

My Biography & Research


Through more than 550 publications, Balistreri has helped to clarify the understanding of many aspects of liver diseases in children.

Balistreri has been editor of The Journal of Pediatrics since 1995. He is the former editor-in-chief of the Journal of Pediatric Gastroenterology and Nutrition, and co-editor, associate editor, guest editor, reviewer and member of numerous editorial boards of several journals. He is co-editor of the prestigious text Liver Disease in Children.

In 2000, Balistreri became the first pediatrician to serve as president of the American Association for the Study of Liver Diseases. He has received numerous awards. These include the Distinguished Leadership Award from the CCFA; the Andrew Sass-Kortsak Memorial Award from the Canadian Liver Foundation and the Canadian Association for the Study of Liver; the Murray Davidson Award from the American Academy of Pediatrics; the prestigious Shwachman Award from the NASPGHAN; the Founder's Award, Cincinnati Pediatric Society; The Distinguished Alumnus Award, University of Buffalo; The Daniel Drake Medal, University of Cincinnati, College of Medicine; the Distinguished Service Award from AASLD; and the Distinguished Educator Award from the American Gastroenterological Association. He received the Outstanding Pediatrician award from the Ohio Chapter of the American Academy of Pediatrics for distinguished achievements in pediatric care and in the education of patients and physicians.

In 2012, NASPGHAN established the William F. Balistreri, MD, Prize for Excellence in Pediatric Gastroenterology, Hepatology and Nutrition. This award will recognize outstanding achievement in an area relevant to the field to be bestowed each year at the annual NASPGHAN meeting.

Balistreri joined Cincinnati Children's in 1978. He served as division director of Pediatric Gastroenterology, Hepatology, and Nutrition for 25 years.

Balistreri has been listed multiple times in Best Doctors in America.

Clinical Interests

Liver disease (cholestasis, viral hepatitis, metabolic liver disease; liver transplantation); celiac disease.

Academic Affiliation

Professor, UC Department of Pediatrics

Clinical Divisions

Gastroenterology GI, Liver Care, Liver Transplant, Autoimmune Liver Disease

Research Divisions


My Locations

My Education

BA: State University of New York at Buffalo, NY, 1966.

MD: University of Buffalo School of Medicine, NY, 1970.

Internship: Cincinnati Children's Hospital Medical Center (University of Cincinnati School of Medicine), Cincinnati, OH, 1970 to 1972.

Residency: Cincinnati Children's Hospital Medical Center (University of Cincinnati School of Medicine), Cincinnati, OH, 1971 to 1972.

Fellowship: Pediatric Gastroenterology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 1973 to 1974.

Research Fellowship: Gastroenterology, Mayo Foundation, Mayo Clinic, Rochester, MN, 1973 to 1975.

Certification: Pediatrics, 1975 (renewed 1992); Pediatric Gastroenterology and Nutrition, 1990 (certificate #2; renewed 1997, 2004, and 2014).

Subspecialty Certification: 2006, American Board of Pediatrics (certificate #004 Pediatric Transplant Hepatology).

My Publications

Treatment of Hepatitis C: A New Paradigm toward Viral Eradication. Squires, JE; Balistreri, WF. The Journal of Pediatrics. 2020; 221:12-U65.

Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C. Schwarz, KB; Rosenthal, P; Murray, KF; Honegger, JR; Hardikar, W; Hague, R; Mittal, N; Massetto, B; Brainard, DM; Hsueh, C; et al. Hepatology. 2020; 71:422-430.

Sofosbuvir and Ribavirin Therapy for Children Aged 3 to < 12 Years With Hepatitis C Virus Genotype 2 or 3 Infection. Rosenthal, P; Schwarz, KB; Gonzalez-Peralta, RP; Lin, C; Kelly, DA; Nightingale, S; Balistreri, WF; Bansal, S; Jonas, MM; Massetto, B; et al. Hepatology. 2020; 71:31-43.

The Journal of Pediatrics-Goals and Successes. Balistreri, WF; McDevitt, M. The Journal of Pediatrics. 2019; 212:4-5.

Fatal Neonatal Hepatic Steatosis: A New Familial Disorder. Khan, S; Balistreri, W. The Journal of Pediatrics. 2019; 210:145-145.

Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11. Murray, KF; Balistreri, WF; Bansal, S; Whitworth, S; Evans, HM; Gonzalez-Peralta, RP; Wen, J; Massetto, B; Kersey, K; Shao, J; et al. Hepatology. 2018; 68:2158-2166.

Enhancing the Development and Retention of Physician-Scientists in Academic Pediatrics: Strategies for Success. Alvira, CM; Steinhorn, RH; Balistreri, WF; Fineman, JR; Oishi, PE; Padbury, JF; Kinsella, JP; Abman, SH. The Journal of Pediatrics. 2018; 200:277-284.

Health-related Quality of Life in Adolescent Patients With Hepatitis C Genotype 1 Treated With Sofosbuvir and Ledipasvir. Younossi, ZM; Stepanova, M; Balistreri, W; Schwarz, K; Murray, KF; Rosenthal, P; Bansal, S; Hunt, S. Journal of Pediatric Gastroenterology and Nutrition. 2018; 66:112-116.

Sofosbuvir and Ribavirin in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 2 or 3 Infection. Wirth, S; Rosenthal, P; Gonzalez-Peralta, RP; Jonas, MM; Balistreri, WF; Lin, C; Hardikar, W; Kersey, K; Massetto, B; Kanwar, B; et al. Hepatology. 2017; 66:1102-1110.

The Safety and Effectiveness of Ledipasvir-Sofosbuvir in Adolescents 12-17 Years Old With Hepatitis C Virus Genotype 1 Infection. Balistreri, WF; Murray, KF; Rosenthal, P; Bansal, S; Lin, C; Kersey, K; Massetto, B; Zhu, Y; Kanwar, B; German, P; et al. Hepatology. 2017; 66:371-378.